跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUPER-C SPF 30 - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SUPER-C SPF 30
Authorized
STANDARD
SUPER-C SPF 30
strivectin operating company inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1e4b3bb6f6d470b7
Company
strivectin operating company inc
Type
Standard
Approval Details
Approval Id
1e4b3bb6f6d470b7
Drug Approval Canada Name
SUPER-C SPF 30
Product Name
SUPER-C SPF 30
Status
Marketed
Status Date
2022-05-09
Original Market Date
2022-05-09
Din
02518279
Drug Class
Human
Dosage Form
Lotion
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:80.00
Atc Original
D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION
Atc Name
d 02 ba 30
Aig Number
0451521103
Company Name
strivectin operating company inc
Company Address
285 Madison Ave, Suite 1200, New York, New York, United States, 10017
Active Ingredients
AVOBENZONE
3 % / W/W
OCTOCRYLENE
10 %
OCTISALATE
4.5 %
HOMOSALATE
7 %
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1e4b3bb6f6d470b7
Type
Standard
Back to Health Canada Approvals